Zentara
Zentara is pioneering Alzheimer's prevention research by integrating cutting-edge neuroscience with practical healthcare solutions. Their innovative approach focuses on early detection and intervention, utilizing AI-powered insights and blood-based biomarkers to identify high-risk individuals. With a global collaboration network and novel financial instruments, Zentara aims to make early intervention financially viable and accessible, addressing the projected $2.8 trillion cost of neurodegenerative diseases by 2030. Their dual-action therapy combines CRISPR-engineered solutions with synthetic neurosteroids, showing promise in reducing cognitive decline markers. Led by experts from Tel Aviv's biotech corridor, Zentara is positioned to revolutionize the prevention of neurodegenerative diseases.
Zentara
Zentara is pioneering Alzheimer's prevention research by integrating cutting-edge neuroscience with practical healthcare solutions. Their innovative approach focuses on early detection and intervention, utilizing AI-powered insights and blood-based biomarkers to identify high-risk individuals. With a global collaboration network and novel financial instruments, Zentara aims to make early intervention financially viable and accessible, addressing the projected $2.8 trillion cost of neurodegenerative diseases by 2030. Their dual-action therapy combines CRISPR-engineered solutions with synthetic neurosteroids, showing promise in reducing cognitive decline markers. Led by experts from Tel Aviv's biotech corridor, Zentara is positioned to revolutionize the prevention of neurodegenerative diseases.